Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Mylan Inc. announced the appointment of former Merrill Lynch investment banker Andrew G. Cuneo as vice president of Global Business Development. Cuneo is responsible for coordinating Mylan's global business development and strategic efforts in close alignment with the company's executive leadership team. Mylan's Vice Chairman and CEO Robert J. Coury said: "Drew brings a wealth of experience in the pharmaceutical, biotechnology and health care sectors. His familiarity with our industry - and in particular with Mylan given his and Merrill Lynch's active role with the company during the past five years - makes him ideally suited to support the company's continued growth."

Today in Execs on the Move...keeping you current

New CEO announced for CAMH
Canadian Healthcare Technology, 11/20/09

Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
Mylan, 11/19/09

Storrer to Lead MEDecision
HealthDataManagement, 11/18/09

Today in Research & Development...keeping you current

Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09

Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
BayNews International, 11/25/09

Reports Rate Ambulatory EHR Software
HealthDataManagement, 11/25/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address